MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 13.738

Change

+0.12 (+0.87)%

Market Cap

USD 0.48B

Volume

49.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.42 (-0.90%)

USD 62.43B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.70 (-0.14%)

USD 12.61B
WRD:PA HSBC ETFs Public Limited Compa..

-0.01 (-0.03%)

USD 10.15B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.62 (+0.67%)

USD 8.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.25 (-0.06%)

USD 7.87B
HHH:PA HSBC ETFs Public Limited Compa..

-0.09 (-0.17%)

USD 7.00B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.12 (+0.04%)

USD 6.81B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.39B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.37 (-0.10%)

USD 4.94B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.28 (-0.19%)

USD 4.74B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.67% 53% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.67% 54% F 65% D
Trailing 12 Months  
Capital Gain 20.09% 59% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.09% 59% D- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.90% 60% D- 62% D
Dividend Return 8.90% 61% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.96% 71% C- 87% B+
Risk Adjusted Return 111.68% 99% N/A 96% N/A
Market Capitalization 0.48B 65% D 69% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike